MSCI (NYSE:MSCI) Stock Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/05/2024 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 12/13/2023 | 7.2% | Morgan Stanley | $526 → $600 | Upgrades | Equal-Weight → Overweight |
| 11/01/2023 | 1.84% | RBC Capital | → $570 | Reiterates | Outperform → Outperform |
| 11/01/2023 | 7.2% | Barclays | $650 → $600 | Maintains | Overweight |
| 11/01/2023 | -6.02% | Morgan Stanley | $532 → $526 | Maintains | Equal-Weight |
| 11/01/2023 | -4.77% | Raymond James | $577 → $533 | Maintains | Outperform |
| 10/18/2023 | 7.2% | JP Morgan | $610 → $600 | Maintains | Overweight |
| 10/05/2023 | 9.52% | Oppenheimer | $620 → $613 | Maintains | Outperform |
| 09/14/2023 | -1.02% | Redburn Partners | → $554 | Downgrades | Buy → Neutral |
| 07/27/2023 | 3.98% | Goldman Sachs | $510 → $582 | Maintains | Neutral |
| 07/26/2023 | -4.95% | Morgan Stanley | $515 → $532 | Maintains | Equal-Weight |
| 07/26/2023 | -2.63% | RBC Capital | → $545 | Reiterates | Outperform → Outperform |
| 07/26/2023 | 14.34% | Wells Fargo | $570 → $640 | Maintains | Overweight |
| 07/26/2023 | 16.13% | Barclays | $600 → $650 | Maintains | Overweight |
| 07/26/2023 | 5.77% | Raymond James | $574 → $592 | Maintains | Outperform |
| 07/17/2023 | -19.6% | Exane BNP Paribas | → $450 | Downgrades | Neutral → Underperform |
| 07/14/2023 | 2.55% | Raymond James | $570 → $574 | Maintains | Outperform |
| 07/05/2023 | 4.16% | Oppenheimer | $595 → $583 | Maintains | Outperform |
| 06/15/2023 | -16.03% | B of A Securities | → $470 | Initiates Coverage On | → Underperform |
| 05/09/2023 | 1.84% | Wells Fargo | → $570 | Initiates Coverage On | → Overweight |
| 04/26/2023 | 7.2% | RBC Capital | → $600 | Reiterates | → Outperform |
| 04/26/2023 | 6.3% | Oppenheimer | $600 → $595 | Maintains | Outperform |
| 04/26/2023 | -7.99% | Morgan Stanley | $551 → $515 | Maintains | Equal-Weight |
| 04/26/2023 | -8.88% | Goldman Sachs | $567 → $510 | Maintains | Neutral |
| 04/26/2023 | 1.84% | Raymond James | $574 → $570 | Maintains | Outperform |
| 04/19/2023 | 5.41% | JP Morgan | $585 → $590 | Maintains | Overweight |
| 04/13/2023 | 2.55% | Raymond James | $549 → $574 | Maintains | Outperform |
| 04/04/2023 | 7.2% | Oppenheimer | $575 → $600 | Maintains | Outperform |
| 03/27/2023 | -1.56% | Morgan Stanley | $543 → $551 | Maintains | Equal-Weight |
| 02/02/2023 | 4.52% | JP Morgan | $580 → $585 | Maintains | Overweight |
| 02/01/2023 | -2.99% | Morgan Stanley | $518 → $543 | Maintains | Equal-Weight |
| 02/01/2023 | 7.2% | RBC Capital | $520 → $600 | Maintains | Outperform |
| 02/01/2023 | 2.73% | Oppenheimer | $510 → $575 | Maintains | Outperform |
| 02/01/2023 | -1.92% | Raymond James | $539 → $549 | Maintains | Outperform |
| 01/04/2023 | -7.45% | Morgan Stanley | $500 → $518 | Maintains | Equal-Weight |
| 12/13/2022 | 3.62% | JP Morgan | → $580 | Initiates Coverage On | → Overweight |
| 12/02/2022 | 7.2% | Barclays | $470 → $600 | Maintains | Overweight |
| 10/26/2022 | -10.67% | Morgan Stanley | $505 → $500 | Maintains | Equal-Weight |
| 10/26/2022 | -8.17% | Raymond James | $499 → $514 | Maintains | Outperform |
| 10/20/2022 | -24.43% | Deutsche Bank | $513 → $423 | Maintains | Hold |
| 10/17/2022 | -10.85% | Raymond James | $510 → $499 | Maintains | Outperform |
| 08/16/2022 | -4.42% | Oppenheimer | $507 → $535 | Maintains | Outperform |
| 08/10/2022 | -8.35% | Deutsche Bank | $478 → $513 | Maintains | Hold |
| 07/29/2022 | -2.45% | UBS | $514 → $546 | Maintains | Buy |
| 07/27/2022 | -9.24% | Morgan Stanley | $515 → $508 | Maintains | Equal-Weight |
| 07/27/2022 | -8.88% | Raymond James | $493 → $510 | Maintains | Outperform |
| 07/20/2022 | -7.99% | Morgan Stanley | $540 → $515 | Maintains | Equal-Weight |
| 07/15/2022 | -11.92% | Raymond James | $515 → $493 | Maintains | Outperform |
| 06/28/2022 | -7.1% | RBC Capital | $600 → $520 | Maintains | Outperform |
| 06/24/2022 | -16.03% | Barclays | $570 → $470 | Maintains | Overweight |
| 04/28/2022 | -7.99% | Raymond James | → $515 | Upgrades | Market Perform → Outperform |
| 04/27/2022 | -14.78% | Deutsche Bank | $533 → $477 | Maintains | Hold |
| 04/27/2022 | 1.84% | Barclays | $700 → $570 | Maintains | Overweight |
| 04/27/2022 | -3.52% | Morgan Stanley | $593 → $540 | Maintains | Equal-Weight |
| 04/01/2022 | -1.2% | Goldman Sachs | → $553 | Initiates Coverage On | → Neutral |
| 03/30/2022 | -4.77% | Deutsche Bank | → $533 | Initiates Coverage On | → Hold |
| 01/28/2022 | 5.95% | Morgan Stanley | $651 → $593 | Maintains | Equal-Weight |
| 01/05/2022 | 16.31% | Morgan Stanley | $600 → $651 | Maintains | Equal-Weight |
| 10/27/2021 | 7.2% | Morgan Stanley | $570 → $600 | Maintains | Equal-Weight |
| 10/27/2021 | 27.39% | Oppenheimer | $685 → $713 | Maintains | Outperform |
| 09/23/2021 | 1.84% | Morgan Stanley | $523 → $570 | Maintains | Equal-Weight |
| 09/21/2021 | 28.64% | RBC Capital | $650 → $720 | Maintains | Outperform |
| 07/28/2021 | 7.2% | Deutsche Bank | $525 → $600 | Maintains | Buy |
| 07/28/2021 | -6.56% | Morgan Stanley | $480 → $523 | Maintains | Equal-Weight |
| 07/28/2021 | 11.84% | Oppenheimer | $566 → $626 | Maintains | Outperform |
| 07/08/2021 | 7.2% | RBC Capital | → $600 | Initiates Coverage On | → Outperform |
| 06/16/2021 | -2.99% | Oppenheimer | $533 → $543 | Maintains | Outperform |
| 05/27/2021 | -14.24% | Morgan Stanley | $473 → $480 | Maintains | Equal-Weight |
| 04/28/2021 | -15.49% | Morgan Stanley | $448 → $473 | Maintains | Equal-Weight |
| 04/28/2021 | -4.77% | Oppenheimer | $493 → $533 | Maintains | Outperform |
| 03/12/2021 | -15.14% | Deutsche Bank | → $475 | Initiates Coverage On | → Buy |
| 02/01/2021 | -17.28% | UBS | $452 → $463 | Upgrades | Neutral → Buy |
| 01/29/2021 | -19.96% | Morgan Stanley | $422 → $448 | Maintains | Equal-Weight |
| 01/06/2021 | -24.61% | Morgan Stanley | $391 → $422 | Maintains | Equal-Weight |
| 10/28/2020 | -30.14% | Morgan Stanley | $384 → $391 | Maintains | Equal-Weight |
| 10/20/2020 | -31.39% | Morgan Stanley | $366 → $384 | Maintains | Equal-Weight |
| 10/06/2020 | -25.68% | Oppenheimer | → $416 | Initiates Coverage On | → Outperform |
| 07/29/2020 | -33% | UBS | $342 → $375 | Maintains | Neutral |
| 07/29/2020 | -34.61% | Morgan Stanley | $337 → $366 | Maintains | Equal-Weight |
| 07/10/2020 | -39.79% | Morgan Stanley | $314 → $337 | Maintains | Equal-Weight |
| 07/08/2020 | -10.49% | BMO Capital | $346 → $501 | Maintains | Outperform |
| 04/30/2020 | -38.18% | BMO Capital | $311 → $346 | Maintains | Outperform |
| 04/29/2020 | -43.9% | Morgan Stanley | $299 → $314 | Maintains | Equal-Weight |
| 04/22/2020 | -46.58% | Morgan Stanley | $274 → $299 | Maintains | Equal-Weight |
| 04/01/2020 | -44.44% | BMO Capital | $336 → $311 | Maintains | Outperform |
| 03/13/2020 | -52.12% | UBS | $299 → $268 | Maintains | Neutral |
| 02/12/2020 | — | Atlantic Equities | Upgrades | Neutral → Overweight | |
| 01/31/2020 | -51.05% | Morgan Stanley | $255 → $274 | Maintains | Equal-Weight |
| 01/31/2020 | -40.15% | Wells Fargo | $270 → $335 | Maintains | Overweight |
| 01/31/2020 | -46.58% | UBS | $285 → $299 | Maintains | Neutral |
| 01/24/2020 | -54.44% | Morgan Stanley | $253 → $255 | Maintains | Equal-Weight |
| 11/04/2019 | -52.12% | BMO Capital | $252 → $268 | Maintains | Outperform |
| 11/01/2019 | -51.76% | Wells Fargo | $260 → $270 | Maintains | Outperform |
| 10/11/2019 | -61.05% | Buckingham Research | $222 → $218 | Maintains | Neutral |
| 10/02/2019 | -57.48% | UBS | $235 → $238 | Maintains | Neutral |
| 09/25/2019 | -58.01% | Atlantic Equities | → $235 | Initiates Coverage On | → Neutral |
| 07/19/2019 | -57.12% | Morgan Stanley | $223 → $240 | Maintains | Equal-Weight |
| 07/08/2019 | -53.91% | UBS | $234 → $258 | Downgrades | Buy → Neutral |
| 06/13/2019 | -60.16% | Morgan Stanley | $216 → $223 | Maintains | Equal-Weight |
| 01/25/2019 | -69.45% | Buckingham Research | → $171 | Initiates Coverage On | → Neutral |
| 01/08/2019 | -71.59% | Morgan Stanley | $172 → $159 | Maintains | Equal-Weight |
| 01/07/2019 | -70.52% | Barclays | $175 → $165 | Maintains | Overweight |